Phase
Condition
Autism
Tic Disorders
Treatment
N/AClinical Study ID
Ages 9-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Meets DSM-IV diagnostic criteria for chronic tic disorder (chronic motor or vocal ticdisorder or Tourette syndrome)
Score of at least 3 on the Clinical Global Impressions Severity Scale
Score of at least 14 on the Yale Global Tic Severity Scale (YGTSS) or at least 10 forindividuals with motor tics only
Unmedicated or currently on a stable medication treatment for tics, obsessivecompulsive disorder (OCD), ADHD, anxiety, and/or depressive disorder for at least 6weeks, with no planned changes for the duration of study participation
Child speaks English
Exclusion
Exclusion Criteria:
Score greater than 30 on the YGTSS
IQ less than 80 on the Wechsler Abbreviated Scale of Intelligence (WASI)
Meets DSM-IV criteria for substance abuse or dependence within the 3 months prior tostudy entry
Meets DSM-IV criteria for conduct disorder within the 3 months prior to study entry
Lifetime DSM-IV diagnosis of pervasive developmental disorder, mania, or psychoticdisorder
Any serious psychiatric, psychosocial, or neurological condition (i.e., OCD, ADHD,major depressive disorder, anxiety, severe aggression, or family discord) requiringimmediate treatment other than what is provided in the current study (i.e.,medication, school intervention, or family therapy)
Previous treatment with four or more sessions of HRT for tics
Study Design
Study Description
Connect with a study center
UCLA Child OCD, Anxiety, and Tic Disorders Program
Los Angeles, California 90402
United StatesSite Not Available
Johns Hopkins University
Baltimore, Maryland 21287
United StatesSite Not Available
University of Wisconsin-Milwaukee
Milwaukee, Wisconsin 53211
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.